Molecular Partners aims to test a COVID-19 drug candidate on people during 2020, Chief Executive Patrick Amstutz said, as the Swiss company hopes that project will help it recover from the failure of the eye drug abicipar.

Swiss drugmakers Roche and Novartis underscored how their portfolios are increasingly clashing on the commercial battlefield, announcing new data on drugs aimed at capturing market share from each other.

Med Ad News interviewed Josh Prince, CEO of DDB Health, CMO of Omnicom Health Group and Jury President of Health & Wellness Lions 2016.